Provide lobbying support on key issues and providing intelligence and policy tracking for relevant federal policy developments that could impact the pharmaceutical and medical device industry generally, and Bayer specifically
2025 · 4th Quarter (Oct 1 - Dec 31)
BAYER CORPORATION
Filed by BGR GOVERNMENT AFFAIRS.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- BGR GOVERNMENT AFFAIRS
- Client
- BAYER CORPORATION
- Filing UUID
- 3e80e4db-22f5-40f6-b279-a89ab9f84c8a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.